Skip to main content
. 2021 Aug 18;11:689843. doi: 10.3389/fonc.2021.689843

Figure 1.

Figure 1

Management schedule for an experienced MDT for PCNSLs. Suspected PCNSL patients visit the clinics, followed by the detection of brain by CT/MRI. If there is a preferred mass in the brain, the patients will receive stereotactic biopsy or resection by neurosurgery. The pathological diagnosis will be made by the Department of Pathology. PET/CT will be mainly used to differentiate the PCNSL from secondary CNSL. After that, the condition of the confirmed patients will be further evaluated and the precise treatment will be discussed by hematologists and irradiation oncologists in an MDT meeting. After the treatment, patient follow-up will be made.